Background
Methods and Result
Silver nanoparticles used in this study were 18.3±2.6 nm in size, uncoated, spherical, regular shape and their zeta potential was -29.1±2.4 mV as measured by transmission electron microscopy (TEM) and zetasizer. The release of silver (Ag) from AgNPs was measured in cell culture medium by atomic absorption spectroscopy (AAS). The exposure of human osteoblast cells (hFOB 1.19) to AgNPs at concentration of 30 or 60 μg/mL for 24 or 48 hours, respectively resulted in cellular uptake of AgNPs and changes in cell ultrastructure. These changes were associated with apoptosis and necrosis as shown by flow cytometry and lactate dehydrogenase (LDH) assay as well as increased levels of pro-apoptotic Bax and decreased levels of anti-apoptotic Bcl-2 mRNA and protein. Importantly, we have found that AgNPs elevated the levels of nitric oxide (NO) with concomitant upregulation of inducible nitric oxide synthase (iNOS) mRNA and protein. A significant positive correlation was observed between the concentration of AgNPs and iNOS at protein and mRNA level (r = 0.837, r = 0.721, respectively; p<0.001). Finally, preincubation of osteoblast cells with N-iminoethyl-L-lysine (L-NIL), a selective iNOS inhibitor, as well as treating cells with iNOS small interfering RNAs (siRNA) significantly attenuated AgNPs-induced apoptosis and AgNPs, similar to other NPs, have the ability to generate reactive oxygen and nitrogen species and oxidative damage in various cells [21, 22] . Nitric oxide is a signaling molecule generated by nitric oxide synthase (NOS) that plays an important role in homeostasis [23] . However, aberrant generation or metabolism of NO increase the oxidizing stress and cellular damage brought about by oxidants such as peroxynitrite (ONOO - ) and nitrogen dioxide (NO 2 ) [21, 24, 25] . These reactive nitrogen species (RNS) react with tyrosine residues in protein to form 3-nitrotyrosine (NT) the indicators of nitrosative stress [24, 25] . Both the regulatory and detrimental effects of NO have been associated with osteoblast metabolism [25] [26] [27] [28] . Furthermore, NO was found to be implicated in xenobiotics-induced bone toxicity [29, 30] . In human osteoblasts NO can be synthesized by all three NOS isoforms i.e. eNOS, nNOS and iNOS [25, 31] . However, the expression of iNOS has been associated with bone injury and disease more frequently than other isoforms [25, [31] [32] [33] .
Considering all the information, the aim of our study was to examine mechanisms of AgNPs-induced cell injury in cultured human osteoblasts with special emphasis on the role of NO and iNOS. We felt that a better understanding of the interaction between AgNPs and osteoblast cells may improve the efficacy and safety of AgNPs-containing prosthetic devices. Therefore, we tested a range of concentrations of AgNPs to find the concentrations capable of exerting apoptosis and necrosis. Finally, we studied molecular mechanisms responsible for osteoblast cell death. Transmission Electron Microscope JEM-1200 EX II TEM (JEOL, Tokyo, Japan) and Dynamic light scattering (DLS) with a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) were used to characterized AgNPs used in the present study.
Materials and Methods

Characterization of AgNPs
Briefly, TEM samples were prepared by placing a drop of the AgNP dispersed at a concentration of 1 mg/mL in ultrapure water (Milli-Q) onto a formvar-coated copper grid and drying at room temperature. AgNPs were directly examined by TEM operated at an accelerating voltage of 200 keV and diameters of 200 particles were measured to determine the mean size and size distribution.
The zeta potentials, polydisperity index and the aggregation profile (hydrodynamic diameter) of the AgNPs were obtained by DLS with a Zetasizer Nano ZS. AgNPs at concentrations of 30 and 60 μg/mL were prepared in serum-free (SF) culture medium and the measurements were performed within 1 hour four times at room temperature. The aggregation profile of AgNPs was also determined after 24, and 48 hours of incubation at 37°C and 5% CO 2 (preconditioned medium).
1 mL of cell culture medium preconditioned with the highest working concentration of 60 μg/mL AgNPs, was used to determine the Ag release. Briefly, after centrifugation (90 min, 20 000 rpm, 0°C) the supernatant was acidified to a pH <2 with 65% HNO 3 , followed by digestion with 65 wt% HNO 3 and 30 wt% HCl [34] . The Ag content in solution was determined using atomic absorption spectrophotometer (AAS, Atomic absorption 800, Perkin Elmer) with a detection limit of 5 μg/L. Triplicate readings were analyzed for each sample.
The supernatant, obtained after centrifugation of medium preconditioned with AgNPs, was also incubated with hFOB 1.19 cells for 24 or 48 h in order to determine potential cytotoxic effect of dissolved Ag (indicated as Ag released from AgNPs).
Additionally, all these measurements were performed for AgNPs prepared in SF culture medium in the presence of 500 μM L-NIL or 60 μM necrostatin-1 (Nec-1) (data not shown).
Cells
Human fetal osteoblast cells (hFOB 1.19) were obtained from the American Type Culture Collection (ATCC number: CRL-11372; Manassas, VA, USA). The cells were maintained at 37°C in 5% CO 2 in flask with a mixture of Dulbecco's Modified Eagle's Medium and Ham F12 medium (1:1 ratio) containing 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin as previously described [35] .
Treatments hFOB 1.19 cells were incubated with AgNPs at concentration of 30 and 60 μg/mL for 24 and 48 hours. The concentrations of AgNPs used in the study were based on results of preliminary concentration-response curves (S1 Fig). 1 mg/mL stock solutions of the AgNPs were prepared in SF culture medium, further dilutions were also made in cell culture medium. All solutions were prepared ex tempore every time just before adding to the cells.
According to manufacturer's instructions AgNPs were shaken for 1 min before use to avoid nanoparticle aggregation. Each of the experiments consists of a control group: cells treated with SF culture medium without NPs. For some experiments L-N 6 -(1-iminoethyl)-lysine (L-NIL), a selective iNOS inhibitor (Sigma-Aldrich, Poland) or Nec-1, a pharmacological inhibitor of necroptosis (Sigma-Aldrich, Poland), was added 1 hour prior the addition of AgNPs to the cells. The concentration of L-NIL (500 μM) and Nec-1 (60 μM) was selected based on preliminary experiments ( S2 Fig and S3 Fig) . Preincubation of cells with 500 μM L-NIL (in the absence of AgNPs) exerted no significant effects on investigated parameters.
TEM analysis hFOB 1.19 cells were cultured in T-25 cm 2 flasks in complete medium until confirmed to be 80-90% confluent. Next, the cells were treated as indicated in section Treatment, and TEM analysis and observation with a JEM 1200 EXII TEM was carried out according to previously published method [35] .
Western blotting of iNOS, NT, Bax and Bcl-2
Western blotting method was used in order to study protein levels of iNOS, Bax and NT. Briefly, osteoblast cells were cultured in 10 cm Petri dishes and incubated with AgNPs or in combination with L-NIL as indicated in section Treatments. Next, cell culture media were removed, cells rinsed three times with phosphate buffer, detached and homogenized in protein lysis buffer in the presence of protease inhibitors (20 mM Tris (pH 7.5), 135 mM NaCl, 2 mM DTT, 2 mM EDTA, 2 mM sodium pyrophosphate, 25 mM b-glycerophosphate, 1% Triton X-100, 10% glycerol, 1 mM sodium orthovanadate, 10 mM NaF, 10 μg/ml aprotinin, 10 μg/ml leupeptin and 1 mM phenylmethylsulfonyl fluoride). The resultant homogenates were centrifuged, collected and protein concentrations were measured by Bradford method. The samples (40 μg protein per lane) were boiled for 5 minutes and separated by SDS-PAGE on polyacrylamide gel and transferred onto nitrocellulose membrane, which was blocked with 5% non-fat dry milk-PBST buffer (phosphate-buffered saline (PBS) containing 0.1% Tween-20) for 1 hour at room temperature and incubated at 4°C for overnight with rabbit polyclonal antibody: antiBax, anti-Bcl-2 (diluted 1:500), anti-iNOS (diluted 1:1000); monoclonal mouse anibodies: and anti-NT (diluted 1:1000) and anti-rabbit IgG or anti-mouse as the secondary antibody (1:20 000). All antibodies used in this study were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The immunoactive proteins were determined using an enhanced chemiluminescence (ECL) Western blotting detection kit (Amersham Biosciences, Piscataway, NJ, USA). The same membrane was stripped and β-actin (Sigma Aldrich) was used as an internal control. Western blotting analysis and protein bands quantification was performed as previously reported by our group [22, 35] .
Cell apoptosis and necrosis
Apoptotic and necrotic cells were measured by Annexin V binding and propidium iodide uptake using apoptosis assay kit (BD Pharmingen, USA 
RT-PCR
Real-time (RT)-PCR was used to measure mRNA levels of Bax in the absence or presence of L-NIL and iNOS. hFOB 1.19 cells were cultured in T-25 cm 2 flasks in complete medium until 80-90% confluent. The cells were treated as indicated in section Treatment. Next, medium was aspirated, the cells were rinsed with phosphate-buffer saline and collected. DNA-free RNA was isolated using a RiboPure Kit (Ambion, Huntingdon, UK according to the supplier's instruction and RNA in each sample was quantified using a NanoDrop ND-1000 spectrophotometer (Fisher Scientific, Ireland). Then, DNA-free RNA from samples were reverse-transcribed using a high-capacity cDNA reverse transcription kit (Applied Biosystems, UK). RT-PCR as well as quantitative analysis was conducted as previously reported by our group [22, 29, 36] . The sequences of the primers of iNOS (accession number: XM_034166), Bax (accession number: NM_004324) and Bcl-2 (accession number: NM_000633.2) were: 5'-ACAACAAATT CAGGTACGCTGTG-3',5' (junction exon 15/16) TCTGATCAATGTCATGA GCAAAGG-3' (exon 16) and 5'-TGGAGCTGCAGAGGATGATTG-3' (junction exon 4/5), 5'-GAAGTTGCC GTCAGAAAACATG-3' (exon 5), and forward primer (exon 2): 5 0 -GGTGCCACCTGTGGT CCA-3 0 , reverse primer (exon 3): 5 0 ACTTGTGGCCCAGATAGG-3 0 , respectively. The location of forward primers ensure detection only mRNA of selected gene. The PCR conditions were as follows: incubation for 10 min at 95°C, followed by 45 cycles of denaturation at 95°C for 10 sec, annealing at 60°C for 15 sec, and extension at 72°C for 20 sec. The expression of each gene was normalized against 18S rRNA (accession number: X03205) expression and expressed relative to the control sample using the formula 2−(ΔΔCt), in which ΔΔCt = (Ct mRNA-Ct 18S rRNA) sample-(Ct mRNA-Ct 18S rRNA) control.
Nitric oxide measurement
The levels of NO in the presence or absence of AgNPs were measured following conversion of nitrate to nitrite using the Griess reagent (Stressgen colorimetric diagnostic kit). Briefly, the cells were seeded into 24-well plates at a concentration of 10 5 cells/well. 24 hours after culturing, cells were incubated in the presence or absence of L-NIL as indicated in section Treatments. Nitrite concentrations were determined using a standard curve of sodium nitrate and nitrite levels in the cell culture supernatants. Media without cells in the presence of the of 30 or 60 μg/mL AgNPs was used as background control and their absorbance were subtracted from the reading of the samples.
Nitrotyrosine measurement
The minutes. Nitrotyrosine levels were measured according to instruction provided by the supplier. The absorbance was measured at 450 nm and nitrotyrosine concentrations were determined using a standard curve of a nitrotyrosine labeled albumin. Absorbance values were also corrected with blank AgNPs. Results were expressed as nmol/mg protein.
iNOS siRNA silencing
In brief, hFOB 1.19 cells were grown to 80% confluence in 6-well plates and transfected with iNOS siRNA using Lipofectamine 2000 (Invitrogen, Poland) in accordance with the protocol of the manufacturer. To control for possible non-specific effects of siRNA, Stealth RNAi™ siRNA negative controls were applied. To optimize the efficiency of transfection, different ratio mixtures of siRNA and Lipofectamine were investigated (data not shown) and 50 nM siRNA was selected. Optimal results were achieved at 24 hours. Effective knockdown of iNOS was confirmed by Western blot analysis. 24 hour after transfection, cells were exposed to 60 μg/mL AgNPs (the highest tested concentration) for 48 h and subjected to western blot, flow cytometer experiments as well as determination of NO and NT level as described above. Cells treated with SF culture medium without NPs were used as a control.
Protein content
Protein-content was measured by the method of Bradford [38] using Coomassie Protein Assay Kit (Thermo Fisher Scientific, USA). Measurements were performed according to protocol provided by supplier.
Statistical analysis
All data are presented as the mean ± standard error of 3-4 independent experiments. Statistical analysis was determined by one-way analysis of variance and Tukey's post-hoc test, and P-values <0.05 were considered statistically significant. All statistical analyses were performed using GraphPad Prism software (GraphPad Software, Inc, La Jolla, CA, USA). Pearson correlation analysis was performed to study the relation between concentration of AgNPs and iNOS at protein and mRNA level.
Results and Discussion
This study provides the evidence that 18 nm uncoated AgNPs enter the cell and that NO generated by iNOS is implicated in AgNPs-induced apoptosis and necrosis in human hFOB 1.19 cells, an established osteoblast model [39] . Importantly, preincubation of osteoblast cells with (L-NIL), a selective iNOS inhibitor, as well as silencing of the iNOS with siRNA significantly attenuated / protected AgNPs-induced apoptosis and necrosis confirming the involvement of iNOS in this process.
Characterization of AgNPs
Physicochemical properties of NPs can determine pharmacological and toxicological outcomes of NPs-cell interactions [7, 21, 22] . It has been reported that significant deviations from nominal specifications are present in commercially supplied samples [21] . Therefore, first, we characterize the supplied AgNPs dispersed in ultrapure water or serum free culture medium, suitable for hFOB 1.19 cells using TEM and Zetasizer. During TEM analysis we have found that AgNPs had a regular, spherical shape and sizes ranging from 10 to 26 nm with a mean diameter of 18.3±2.6 nm, which is similar to size specified by manufacturer: 15 nm (Fig 1) . To characterize AgNPs under the conditions of biological exposure the zeta potential and the polydispersity index were measured after dispersion of AgNPs (30 and 60 μg/mL) in serum free cell culture medium using Zetasizer. No significant differences in characterization between two used concentration of AgNPs was observed, therefore data obtained for 60 μg/mL AgNPs are shown, as representative. From the obtained data (presented in Table 1 ) it was evident that AgNPs in serum free media were negatively charged and monodispersed at concentrations applied in the study [40] . The soluble Ag present in SF medium after 24 and 48 h exposure to AgNPs at the highest working concentration of 60 μg/mL was detected to be less than 0.3 μg/ mL, which correspondents to less than 0.5% release (Table 1) . These results are in agreement with a study by Gliga et al who detected a small portion of released Ag from AgNPs in cell culture medium [34] . In accordance with other studies [41] , AgNPs formed aggregates in SF culture medium measured by DLS method. The effective diameter (hydrodynamic size) of AgNPs increased in both concentration-and time-dependent manner (Table 1) , presumably because of the high concentration of ionic salts in the medium. It was also confirmed that the presence of L-NIL (500 μM) or Nec-1 (60 μM) in the analyzed samples of AgNPs did not affect investigated parameters (data not shown)
Uptake of AgNPs by hFOB 1.19 cells
We used transmission electron microscopy (TEM) for ultrastructural examination of AgNPsexposed osteoblast cells. The process of fixing, dehydrating, staining, resin embedding, and ultramicrotome sectioning allowed us to visualize uptake and intracellular locations of AgNPs. The electron micrograph ( Fig 2B) shows osmiophilic granular aggregates of AgNPs localized frequently in cellular vacuoles. Single electron dense particles were spherical in shape and the average size of 18 nm. In keeping with our findings, Sengstock et al showed that 80 nm AgNPs were taken up by human mesenchymal stem cells and after 24 h of treatment were visible in the endo-lysosomal cell areas, but not inside the nucleus [42] . The translocation of nanoparticles to the nucleus appears to be size-dependent. Indeed, metal (Au) NPs with a size of 5 nm were found in nuclei of human fibroblast cell line, whereas nanoparticles with size 30 nm or larger were observed in The polydisperity index (PDI) and zeta potential value were obtained from the dynamic light scattering (DLS) measurements using zetasizer. The DLS data were obtained for AgNPs dispersed in SF culture medium at the concentration of 60 μg/mL; the measurements were performed four times at room temperature. *The amount of released Ag in SF cell medium after 24 and 48 h at 37˚C, 5% CO 2 and centrifugation was quantified by AAS and expressed as percentage from the total added AgNPs. Changes in the hydrodynamic diameter of 30 and 60 μg/mL AgNPs is presented after, 0", 24 and 48 hours in SF cell medium at 37˚C, 5% CO 2 . Results are presented as mean ± standard deviation of 4 replicates.
doi:10.1371/journal.pone.0164137.t001
Silver Nanoparticles-Induced Human Osteoblast Cell Death the cytoplasm [43] . However, other study demonstrated that exposure of osteoblast cells to AgNPs with a size 5 nm resulted in their localization inside the lysosomes but not inside the nucleus [18] . On the other hand, nuclear presence has been detected for AgNPs with size 30 nm in HaCaT cells and >50 nm NPs were detected in human mesenchymal stem cells [44, 45] . Also, He et al found that 24 h exposure to AgNPs (30 nm) resulted in their distribution in the cytoplasm, the nucleus and different sized vesicles in human bone marrow-derived mesenchymal stem cells [10] . We have previously found that treatment of human gingival fibroblast cells with 2 AgNPs nm caused their uptake and localization mainly in the mitochondria [22] . However, when human osteoarthritic chondrocytes were incubated for 24 h in the presence of 65 nm AgNPs (250 μM) the intracellular uptake of these NPs could not be detected by TEM [15] . Finally, Park et al described that when RAW264.7 mouse macrophage-like cells were exposed to Ag-NPs, the NPs were found in the cytosol of activated but not damaged cells [46] . The discrepancy in these findings indicates that cellular uptake of AgNPs is very complex and probably depends on many factors, such as size, functionalization, zeta potential, concentration, time of incubation as well as on a type of cells.
Cytotoxicity of AgNPs in hFOB 1.19 cells
Gliga et al have shown that the intracellular uptake of AgNPs is responsible for the nanoparticle cytotoxicity [34] . We have also observed that the uptake of AgNPs by osteoblasts is associated with alterations in cell ultrastructure and signs of injury ( Figs 2C and 3A-3C ). Indeed, osteoblasts exposed to AgNPs at concentration of 30 μg/mL showed the first manifestation of cell injury, such as: swelling of the endoplasmic reticulum [47] (Fig 2C) . On closer ultrastructural examination AgNPs-treated cells showed morphological features characteristic for apoptosis (Fig 3C) including clumping and margination of condensed heterochromatin at the nuclear periphery, decreasing cell volume, increasing nuclear to cytoplasm ratio, apoptotic body formation, loss of microvilli and plasma membrane blebbing in individual cells. This is consistent with the study conducted by Pascaralli et al who showed an increased number of osteoarthritic chondrocytes with evident signs of apoptosis, after treatment with AgNPs at concentrations (160 and 250 μM) [15] . In addition to hallmarks of apoptosis we have also found, ultrastructure changes indicative of necrosis following incubation of hFOB 1.19 with 60 μg/mL AgNPs (Fig 3C) . Interestingly, the ultrastructural examination showed also signs of autophagy (Fig 3B) . This is not surprising given that autophagy is generally thought of as a survival mechanism that regulates the extent of apoptosis and necrosis [48] . During autophagy, parts of the cytoplasm are sequestered within characteristic double-membraned autophagic vacuoles, called autophagosomes and are finally delivered to lysosomes for degradation. Interestingly, the development of double-membrane autophagosomes was observed in various type of AgNPs-treated cells, e.g. mouse embryonic fibroblast cells, male somatic Leydig and Sertoli cells and human liver derived hepatoma cells [49] [50] [51] . It has to be emphasized that, the cross talk between autophagy and apoptosis as well as autophagy, apoptosis and NPs is very complex and still not completely understood. On one hand, deregulated autophagy after NPs treatment may lead to increased Silver Nanoparticles-Induced Human Osteoblast Cell Death cell death, either independently or in conjunction with apoptosis or necrosis [48, [51] [52] [53] . On the other hand, autophagy is also a physiological process maintaining cellular homeostasis and may appear independent of its role in cell death and promote cell survival [53, 54] . Interestingly, exposure of adipogenic and osteogenic cells to 10 and 20 nm AgNPs resulted in cellular uptake and decreased cell viability in the absence of significant ultrastructural alterations [16] .
What molecular mechanisms may be responsible for cytotoxic effects of AgNPs in hFOB 1.19 cells?
AgNPs may cause cell death both in vitro and in vivo. Indeed, AgNPs enhanced apoptosis and upregulation of the p53-related pro-apoptotic genes Bax, Noxa, p21 in the liver of adult zebrafish [55] . The changes in mRNA regulation were caused by AgNPs-induced free radicals. Similarly, other study suggested that AgNPs induced apoptosis through increasing intracellular ROS production in cultured cerebral cortical neurons [56] . Ahamed et al demonstrated that activities of caspase-3 and caspase-9, markers of apoptosis were significantly higher in Drosophila melanogaster exposed to AgNPs [57] . Necrosis induction by AgNPs exposure in cell culture was also documented. Treatment of epidermoid larynx carcinoma cells with 31 nm AgNPs resulted in a significant elevation of LDH activities in the cell culture medium [58] . Finally, Gliga et al observed that 10 nm AgNPs caused membrane damage of human lung cells [34] . The cytotoxicity of AgNPs in osteoblasts appears to be dependent on the size of nanoparticles. For example, Kim et al ascertained that AgNPs enhanced apoptosis in mouse osteoblastic cells (MC3T3-E1) in nanoparticle size-dependent manner [59] . AgNPs < 10 nm induced apoptosis, but not 50 and 100 nm. The coating of NPs can also influence their cytotoxicity. However, the effect is not fully understood. For example, Suresh et al demonstrated that poly (diallyldimethylammonium)-coated AgNPs, biogenic-Ag and oleate-AgNPs were more toxic to macrophage and lung epithelial cells than uncoated AgNPs [60] . Gliga et al showed that cytotoxicity of 10 nm AgNPs in human lung cells was independent of surface coating [34] . Some studies found that toxicity of AgNPs was reduced due to the coatings, which limited direct contact of particle surface with cellular components [61] or have protective effect on the release of Ag ions [62] . It has been demonstrated that the toxicity of AgNPs is associated with the release of Ag ions [63, 64] . However, not only Ag dissolution is the factor contributing to uncoated AgNPs-induced cytotoxicity [62] . Indeed, in our experiment no LDH leakage was detected when osteoblast cells were exposure to Ag released from AgNPs (Fig 4) , indicating that the toxic effects observed after 24 and 48 h were not due to dissolved Ag in cell culture medium. Apoptosis was also not affected by released Ag (S4 Fig). Similarly, Stoehr et al demonstrated that Ag wires-induced loss of human alveolar epithelial cells viability was not due to released Ag ions in cell culture medium [65] . Also, Kim et al suggested that AgNPs-induced cytotoxicity is independent of the toxicity of Ag ions [66] . In these experiments apoptosis was significantly increased from 4.7% (control) to 16.2% following incubation with 60 μg/mL AgNPs for 24 h and from 7% to 18.2% and 27.7% following incubation with 30 and 60 μg/mL AgNPs for 48 h, respectively. This increased number of apoptotic cells was associated with a concentration-and time-dependent increase in proapoptotic Bax and decrease in anti-apoptotic Bcl-2 protein and mRNA levels (Fig 6B and 6D) . The levels of Bax protein increased significantly 3.2, 3.8, 4.8-fold following incubation with 60 μg/mL AgNPs for 24 h and with 30 and 60 AgNPs μg/mL for 48 h, respectively compared to the control. The levels of Bax mRNA in osteoblast cells increased significantly 3.1, 2.9, 6-fold following incubation with 60 μg/mL AgNPs for 24 h and with 30 and 60 AgNPs μg/mL for 48 h, respectively compared to the control. Moreover, the levels of Bcl-2 protein decreased significantly (p<0.01 or p<0.01, p<0.001, n = 3) following incubation with 60 μg/mL AgNPs for 24 h and with 30 and 60 AgNPs μg/mL for 48 h, respectively compared to the control. The levels of Bcl-2 mRNA in osteoblast cells decreased significantly (p<0.05 or p<0.001, n = 3) following incubation with 60 μg/mL AgNPs for 24 h and with 30 and 60 AgNPs μg/mL for 48 h, respectively compared to the control. The presence of the late apoptotic/necrotic cell (Annexin V+ PI+) was very little, not statistically significant. The percentage of dead cells (Annexin V-PI+) osteoblasts increased significantly from 7% (control) to 27.7% following incubation with 60 μg/mL AgNPs and from 6% to 32% and 52.8% following incubation with 30 and 60 μg/mL AgNPs for 48 h, respectively. This results together with ultrastructural observation by TEM and a significant increase of LDH release suggested that necrosis as well as necroptosis may be involved in AgNPs-induced osteoblast death. Indeed, a novel form of cell death, termed necroptosis, shows morphological features similar to necrosis [67] . However, necroptosis is strictly regulated forms of cell death and can be specifically inhibited by Nec-1 [67] . In our study, percent of dead cells (staining with PI) did not significantly reduce when they were pretreated with Nec-1 Silver Nanoparticles-Induced Human Osteoblast Cell Death (Fig 7) . These data indicated that necrosis, but not necroptosis is associated with AgNPsinduced cells death in hFOB 1.19 cells. Nonetheless, our results support the notion that nanoparticles, could cause cell death through a complex mechanism, including apoptosis, necrosis, apoptosis-like, and necrosis-like process [68] and that several types of cell death may be activated simultaneously within cells [53] .
AgNPs induce expression of iNOS and generation of NO and nitrotyrosine formation in hFOB 1.19 cells
It has been shown that NO exerts dual role in osteoblast activities. The constitutive NO plays an important role in regulation of osteoblast proliferation and differentiation [27, 28, 69] . On the other hand, overproduction of NO in response to iNOS expression results in osteoblast injury and may contribute to the pathogenesis of bone diseases [25, 32, 70, 71] . Therefore, we have decided to study the impact of AgNPs on the expression of iNOS and generation of NO in hFOB 1.19 cells. We found that AgNPs enhanced production of NO in osteoblast cells in a Importantly, the addition of 500 μM L-NIL, a selective inhibitor of iNOS [70] prevented AgNPs-induced increase in NO levels indicating that iNOS is responsible for this increase ( Fig  8A) . As expected, AgNPs increased the expression of iNOS, both at protein (p<0.001, n = 4) and mRNA level (p<0.001, n = 4) in hFOB 1.19 cells (Fig 8B and 8C ) in a concentration-and time-dependent manner. Furthermore, a significant positive correlation between AgNPs concentration and iNOS protein and mRNA levels was found (Table 2) .
Interestingly, Pascarellia et al during immunocytochemical study of osteoarthritic chondrocytes observed that 160 and 250 μM AgNPs with size 65 nm significantly increased percentage of cells with an intense iNOS signal inside the cytoplasm compared to the controls [15] . Ramírez-Lee et al reported similar findings in airway smooth muscle cells [72] . Thus, increased expression of iNOS appears to be a common denominator in AgNPs-cell interactions leading to generation of high levels of NO. It has to be noticed that increased generation of NO may also result in the synthesis of powerful oxidants, such as ONOO -and NO 2 [24, 73] . For example, silica nanoparticles induce excessive generation of NO in vascular endothelial cells leading to ONOO − production and endothelial dysfunction [21] . ONOO − is involved, at least partially, in NO-induced deleterious effects on human osteoblast metabolism [74] . Peroxynitriteinduced protein nitration may result in formation of NT [24, 73, 74] . Indeed, we found that an increase of NO production in hFOB 1.19 cells exposed to AgNPs for 48 h led to increased generation of NT (p<0.05, p<0.01, respectively; n = 4) as detected by ELISA and Western blotting. This effect was reversed by preincubation with 500 μM L-NIL (Fig 9A and 9B ).
iNOS expression is implicated in AgNPs-induced hFOB 1.
cell death
It has been demonstrated that NO directly or following conversion to reactive nitrogen species may activate biological signaling to cause cells apoptosis [71, 73, 74] . A number of studies have explored the effects of increased generation of NO on osteoblast apoptosis. Chen et al demonstrated that NO released from NO donor induced osteoblast apoptosis and this was associated with reduced anti-apoptotic Bcl-2 protein [26]. Also, it was suggested that NO causes apoptosis in osteoblasts by increasing the synthesis of Bax protein de novo [75] . Damoulis and Hauschka found that NO is responsible for decreased mouse osteoblast (MC3T3-E1) viability [76] . Exposure of osteoblasts to sodium nitroprusside (SNP), a donor of NO, led to decreased osteoblast viability [77] . Therefore, we hypothesized that the expression of iNOS and increased generation of NO are implicated in AgNPs-induced apoptosis and necrosis in human osteoblasts. To explore our hypothesis, we measured AgNPs-induced apoptosis and necrosis in the presence or absence of L-NIL. Importantly, we found that pre-incubation of hFOB 1.19 cells with L-NIL significantly attenuated (60 μg/mL for 24 h and 30, 60 μg/mL for 48 h) AgNPs-induced apoptosis by 48, 49, 44%, respectively and necrosis by 52, 46, 61%, respectively (Fig 5, Fig 6A and Fig  7) . The reduction of a number of apoptotic cells was accompanied by decreased expression of Bax mRNA (p<0.05 or p<0.001, n = 3) and protein levels (p<0.001, n = 3), which had been elevated following exposure to AgNPs (Fig 6B and 6C) . Also, a significant increase of Bcl-2 at protein and mRNA level (p<0.01 or p<0.001, n = 3) was found (Fig 6B and 6C) .
To further investigate the link between iNOS and AgNPs-induced cell death, osteoblast cells were transfected with iNOS siRNA to silence iNOS expression. We found that in these cells, 60 μg/mL AgNPs failed to increase NO production, NT formation and apoptosis. Also, we have observed that iNOS siRNA significantly reduced the percent of AgNPs-induced dead cells (Annexin V-PI+) (Fig 10A-10E) . These results confirmed the view that AgNPs induced apoptosis and necrosis in human osteoblasts by the iNOS pathway. 
Conclusion
We have found that the exposure of human osteoblasts in vitro to AgNPs with the average size of 18 nm results in nanoparticle uptake and changes in cell ultrastructure leading to apoptosis and necrosis. The cell death was associated with increased level of iNOS mRNA, iNOS protein and generation of increased amounts of NO. The detrimental effects of AgNPs could be attenuated by selective inhibition of iNOS activity using L-NIL or by silencing of the iNOS with siRNA. Thus, caution should be exercised when using AgNPs in prosthetic devices to prevent 
